Which of the following is the standard extent of lymphadenectomy recommended for curative intent gastrectomy in gastric cancer?

Explanation

## Lymphadenectomy Classification in Gastric Cancer Surgery ### Standard of Care: D2 Lymphadenectomy **Key Point:** D2 lymphadenectomy is the gold standard for curative-intent gastrectomy in gastric cancer and is recommended by international guidelines (JGCA, NCCN, ESMO). ### Definition of D2 Lymphadenectomy D2 lymphadenectomy includes removal of: - **Perigastric nodes** (D1): stations 1–6 - Station 1: Right cardia - Station 2: Left cardia - Station 3: Lesser curvature - Station 4: Greater curvature - Station 5: Suprapyloric - Station 6: Infrapyloric - **Regional nodes** (D2 addition): stations 7–11 - Station 7: Left gastric artery - Station 8: Common hepatic artery - Station 9: Coeliac artery - Station 10: Splenic hilum - Station 11: Splenic artery **High-Yield:** D2 lymphadenectomy improves **overall survival by 5–10%** and reduces locoregional recurrence compared to D1 alone, as demonstrated in the Dutch D1D2 trial and subsequent meta-analyses. ### Evidence Base | Trial/Study | Finding | | --- | --- | | Dutch D1D2 Trial (1999) | D2 reduced recurrence but increased morbidity; survival benefit emerged at 15-year follow-up | | Korean KLASS-01 (2015) | D2 laparoscopic gastrectomy safe and effective with lower morbidity than open D2 | | Japanese JGCA Guidelines | D2 is standard for T2 and deeper tumours; D1+ acceptable for T1a without risk factors | | NCCN Guidelines (2023) | D2 recommended for all resectable gastric cancers | **Clinical Pearl:** D2 dissection requires splenectomy and distal pancreatectomy in approximately 20–30% of cases (for tumours at the greater curvature or fundus involving station 10–11 nodes), which increases morbidity but is acceptable for curative intent. ### D1 vs. D2 vs. D3 Comparison ```mermaid flowchart TD A[Gastric Cancer Requiring Gastrectomy]:::outcome --> B{Extent of Lymphadenectomy?}:::decision B -->|D1 Only| C[Perigastric nodes only<br/>Stations 1-6]:::action B -->|D2 Standard| D[Perigastric + Regional<br/>Stations 1-11<br/>Better survival]:::action B -->|D3 Rarely| E[D2 + Distant nodes<br/>Stations 12-16<br/>No survival benefit]:::action C --> F[Lower morbidity<br/>Higher recurrence<br/>Acceptable only for T1a]:::outcome D --> G[Standard of care<br/>5-10% survival benefit<br/>Acceptable morbidity]:::outcome E --> H[Increased morbidity<br/>No proven benefit<br/>Not recommended]:::urgent ``` **Mnemonic:** **D2 = Double the nodes = Duodenum to Coeliac axis** ## When D1 May Be Acceptable - **Early gastric cancer (T1a, N0)** without risk factors (age >80, comorbidities) - **Palliative resection** for symptom control - **Elderly patients** with significant operative risk **Warning:** D1 lymphadenectomy alone is NOT acceptable for T2 or deeper tumours or any N+ disease. [cite:Japanese Gastric Cancer Association Guidelines 5e; NCCN Gastric Cancer Guidelines 2023; Harrison 21e Ch 297]